Home・Elenco Azioni・10X Genomics Inc (Class A)

10X Genomics Inc (Class A)

Aperta

SettoreSettore sanitario

64.11 0.14

Acquista Vendi

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

62.35

Massimo

65.01

Metriche Chiave
By Trading Economics
Entrata	-4.5M -18M
Vendite	193K 151M
EPS	-0.14
Margine di Profitto	-11.872
Dipendenti	1,178
EBITDA	-18M -19M

Raccomandazioni
By TipRanks
Raccomandazioni	Acquista
Previsioni per 12 mesi	-22.19% downside

Dividendi
By Acuity
Utili prossimi	5 nov 2026

Statistiche di mercato
By TradingEconomics
Capitalizzazione di Mercato	2.3B 8.3B
Apertura precedente	63.97
Chiusura precedente	64.11

Notizie sul Sentiment di mercato

By Acuity

13%

87%

16 / 340 Classifica in Healthcare

10X Genomics Inc (Class A) Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

25 ago 2026, 23:21 UTC

10X Genomics Inc shares are higher in after-market hours, though no specific news was identified. Market sentiment improved amid a decline in crude oil prices.

24 ago 2026, 19:26 UTC

Social Media

10X Genomics Inc shares are lower today amid broader market declines and geopolitical tensions, though the stock remains significantly above its 20-day moving average.

21 ago 2026, 23:16 UTC

10X Genomics Inc. shares are higher in after-market trading, continuing gains since Friday's close, amid broader cryptocurrency market strength.

20 ago 2026, 23:16 UTC

10X Genomics Inc. shares traded lower after-market, amid broader market pressure from rising bond yields and concerns over high borrowing costs and geopolitical risks.

19 ago 2026, 23:06 UTC

10X Genomics Inc shares are higher in after-market trading, reflecting strong momentum above the 20-day moving average and near the top of its one-month range.

18 ago 2026, 23:31 UTC

10X Genomics Inc shares are higher in after-market trading, maintaining a notable increase while staying above the 20-day moving average. No specific news was identified.

17 ago 2026, 19:16 UTC

10X Genomics Inc shares are higher today, recovering from an initial dip. The stock remains above its 20-day moving average amid mixed economic indicators.

14 ago 2026, 20:06 UTC

10X Genomics Inc shares are lower today amid mixed market sentiment following a reported decline in U.S. retail sales for July.

13 ago 2026, 19:16 UTC

News

10X Genomics Inc reported Q2 revenue of $151 million, exceeding estimates. Shares are higher as management raises full-year revenue guidance to $620 million.

12 ago 2026, 19:46 UTC

10X Genomics Inc. shares are lower today, having retraced from an early peak. The stock remains above its 20-day moving average.

11 ago 2026, 20:06 UTC

10X Genomics Inc. shares are lower today amid routine trading, despite earlier fluctuations and remaining above the 20-day moving average.

10 ago 2026, 20:03 UTC

News

Social Media

Correlated Moves

10X Genomics shares rise as Piper Sandler and Canaccord Genuity raise price targets to $47.00 and $60.00, respectively, amid increased trading volume.

7 ago 2026, 23:16 UTC

News

10X Genomics Inc shares are lower in after-market trading amid a sector decline. Citigroup raised its price target to $50 while maintaining a Neutral rating.

6 ago 2026, 23:02 UTC

News

10X Genomics reported a net loss of $17.9 million for Q2, with shares trading lower in after-market hours amid concerns over an operating loss.

5 ago 2026, 19:26 UTC

Correlated Moves

News

10X Genomics Inc shares are lower amid broader market declines. The company reported $150.8 million in revenue last quarter, reflecting a year-on-year decline.

3 ago 2026, 19:36 UTC

Correlated Moves

Social Media

10X Genomics Inc reached a new 52-week high, reflecting strong market activity and positive sentiment in the genomics sector. Shares are higher since Friday's close.

31 lug 2026, 19:36 UTC

Correlated Moves

Social Media

10X Genomics shares are lower today, continuing a decline since Thursday's close. The Russell 2000 Index also reflects broader market weakness.

30 lug 2026, 17:06 UTC

Correlated Moves

10X Genomics Inc is higher today, supported by broader market trends and a significant rise since Wednesday's close. The stock peaked intraday with notable gains.

29 lug 2026, 19:27 UTC

Macro Event

News

10X Genomics Inc announced a collaboration with Lausanne University Hospital to enhance cancer diagnostics. Shares are higher since Tuesday's close, reflecting positive sentiment.

28 lug 2026, 23:11 UTC

10X Genomics Inc. is trading higher in after-market hours, maintaining a position near its one-month range's upper end. No specific news was identified for the move.

27 lug 2026, 18:36 UTC

10X Genomics Inc shares are lower today, with no specific news identified. The stock remains near the upper end of its one-month range.

24 lug 2026, 16:26 UTC

10X Genomics Inc shares declined during Friday's session, hitting a session low before a slight recovery. The stock remains above its 20-day moving average.

23 lug 2026, 23:26 UTC

Correlated Moves

10X Genomics Inc shares declined in after-market trading, mirroring a broader market trend. The stock remains near the upper end of its one-month range.

22 lug 2026, 19:51 UTC

Correlated Moves

10X Genomics Inc reports a first-quarter net loss of -$34 million, with revenue falling to $47 million, as shares trade lower amid broader market declines.

21 lug 2026, 19:53 UTC

Correlated Moves

Positive investor sentiment drives 10X Genomics Inc higher amid a broader market recovery, reflecting gains since Monday's close and aligning with small-cap stock interest.

20 lug 2026, 19:16 UTC

News

Correlated Moves

10X Genomics Inc. shares are lower as a report cites only 1.1% annual sales growth and ineffective growth strategies amid a declining Life Sciences Tools sector.

Confronto tra pari

Modifica del prezzo

10X Genomics Inc (Class A) Previsione

Obiettivo di Prezzo

By TipRanks

-22.19% in calo

Previsioni per 12 mesi

Media 50.36 USD -22.19%

Alto 65 USD

Basso 40 USD

Basato su 13 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per 10X Genomics Inc (Class A) - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Acquista

13 ratings

Acquista

Mantieni

Vendi

Basato sugli analisti di 13 che hanno fornito valutazioni azionarie a 10X Genomics Inc (Class A) - Dist negli ultimi 3 mesi.

Sentiment

By Acuity

16 / 340 Classifica in Settore sanitario

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

Chi Siamo 10X Genomics Inc (Class A)

10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in the America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium, chromium connect, and chromium controller instruments, microfluidic chips, slides, reagents, and other consumables products. Its single cell solutions runs on its chromium instruments, which include single cell gene expression for measuring gene activity and networks on a cell-by-cell basis; single cell gene expression flex; single cell immune profiling used to study the immune system; single cell Assay for Transposase Accessible Chromati (ATAC) solution to understand the epigenetic state; and single cell multiome ATAC + gene expression which enables simultaneous interrogation of both the RNA and chromatin accessibility, using ATAC in a single cell. The company also provides Visium platform which enables researchers to understand the spatial positions of biological analytes within tissues at high resolution; and Xenium platform for in situ analysis. It serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.